Cargando…

A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1

INTRODUCTION: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived eBioparticles (eBPs) sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Castenmiller, Charlotte, Nagy, Noémi Anna, Kroon, Pascal Zion, Auger, Lydia, Desgagnés, Réjean, Martel, Caroline, Mirande, Lucie, Morel, Bertrand, Roberge, Joannie, Stordeur, Virginie, Tropper, Guy, Vézina, Louis Philipe, van Ree, Ronald, Gomord, Véronique, de Jong, Esther Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679945/
https://www.ncbi.nlm.nih.gov/pubmed/38020282
http://dx.doi.org/10.1016/j.waojou.2023.100839
_version_ 1785142283074535424
author Castenmiller, Charlotte
Nagy, Noémi Anna
Kroon, Pascal Zion
Auger, Lydia
Desgagnés, Réjean
Martel, Caroline
Mirande, Lucie
Morel, Bertrand
Roberge, Joannie
Stordeur, Virginie
Tropper, Guy
Vézina, Louis Philipe
van Ree, Ronald
Gomord, Véronique
de Jong, Esther Christina
author_facet Castenmiller, Charlotte
Nagy, Noémi Anna
Kroon, Pascal Zion
Auger, Lydia
Desgagnés, Réjean
Martel, Caroline
Mirande, Lucie
Morel, Bertrand
Roberge, Joannie
Stordeur, Virginie
Tropper, Guy
Vézina, Louis Philipe
van Ree, Ronald
Gomord, Véronique
de Jong, Esther Christina
author_sort Castenmiller, Charlotte
collection PubMed
description INTRODUCTION: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived eBioparticles (eBPs) surface expressing Ara h 2 at high density have been shown to be very hypoallergenic. Here, we assessed the dendritic cell (DC)-activating and T cell polarization capacity of these peanut-specific eBPs. METHODS: Route and kinetics of eBP uptake were studied by (imaging) flow cytometry using monocyte-derived DCs incubated with fluorescently-labelled Ara h 2 eBPs or natural Ara h 2 (nAra h 2) in the presence or absence of inhibitors that block pathways involved in macropinocytosis, phagocytosis, and/or receptor-mediated uptake. DC activation was monitored by flow cytometry (maturation marker expression) and ELISA (cytokine production). T cell polarization was assessed by co-culturing DCs exposed to Ara h 2 eBPs or nAra h 2 with naïve CD4(+) T cells, followed by flow cytometry assessment of intracellular IFNγ(+) (Th1) and IL-13(+) (Th2), and CD25(+)CD127(-)Foxp3(+) regulatory T cells (Tregs). The suppressive activity of Tregs was tested using a suppressor assay. RESULTS: Ara h 2 eBPs were taken up by DCs through actin-dependent pathways. They activated DCs demonstrated by an induced expression of CD83 and CD86, and production of TNFα, IL-6, and IL-10. eBP-treated DCs polarized naïve CD4(+) T cells towards Th1 cells, while reducing Th2 cell development. Furthermore, eBP-treated DCs induced reduced the frequency of Foxp3(+) Tregs but did not significantly affect T cell IL-10 production or T cells with suppressive capacity. In contrast, DC activation and Th1 cell polarization were not observed for nAra h 2. CONCLUSION: Ara h 2 eBPs activate DCs that subsequently promote Th1 cell polarization and reduce Th2 cell polarization. These characteristics mark Ara h 2 eBPs as a promising novel candidate for peanut AIT.
format Online
Article
Text
id pubmed-10679945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-106799452023-11-10 A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 Castenmiller, Charlotte Nagy, Noémi Anna Kroon, Pascal Zion Auger, Lydia Desgagnés, Réjean Martel, Caroline Mirande, Lucie Morel, Bertrand Roberge, Joannie Stordeur, Virginie Tropper, Guy Vézina, Louis Philipe van Ree, Ronald Gomord, Véronique de Jong, Esther Christina World Allergy Organ J Full Length Article INTRODUCTION: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived eBioparticles (eBPs) surface expressing Ara h 2 at high density have been shown to be very hypoallergenic. Here, we assessed the dendritic cell (DC)-activating and T cell polarization capacity of these peanut-specific eBPs. METHODS: Route and kinetics of eBP uptake were studied by (imaging) flow cytometry using monocyte-derived DCs incubated with fluorescently-labelled Ara h 2 eBPs or natural Ara h 2 (nAra h 2) in the presence or absence of inhibitors that block pathways involved in macropinocytosis, phagocytosis, and/or receptor-mediated uptake. DC activation was monitored by flow cytometry (maturation marker expression) and ELISA (cytokine production). T cell polarization was assessed by co-culturing DCs exposed to Ara h 2 eBPs or nAra h 2 with naïve CD4(+) T cells, followed by flow cytometry assessment of intracellular IFNγ(+) (Th1) and IL-13(+) (Th2), and CD25(+)CD127(-)Foxp3(+) regulatory T cells (Tregs). The suppressive activity of Tregs was tested using a suppressor assay. RESULTS: Ara h 2 eBPs were taken up by DCs through actin-dependent pathways. They activated DCs demonstrated by an induced expression of CD83 and CD86, and production of TNFα, IL-6, and IL-10. eBP-treated DCs polarized naïve CD4(+) T cells towards Th1 cells, while reducing Th2 cell development. Furthermore, eBP-treated DCs induced reduced the frequency of Foxp3(+) Tregs but did not significantly affect T cell IL-10 production or T cells with suppressive capacity. In contrast, DC activation and Th1 cell polarization were not observed for nAra h 2. CONCLUSION: Ara h 2 eBPs activate DCs that subsequently promote Th1 cell polarization and reduce Th2 cell polarization. These characteristics mark Ara h 2 eBPs as a promising novel candidate for peanut AIT. World Allergy Organization 2023-11-10 /pmc/articles/PMC10679945/ /pubmed/38020282 http://dx.doi.org/10.1016/j.waojou.2023.100839 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Castenmiller, Charlotte
Nagy, Noémi Anna
Kroon, Pascal Zion
Auger, Lydia
Desgagnés, Réjean
Martel, Caroline
Mirande, Lucie
Morel, Bertrand
Roberge, Joannie
Stordeur, Virginie
Tropper, Guy
Vézina, Louis Philipe
van Ree, Ronald
Gomord, Véronique
de Jong, Esther Christina
A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
title A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
title_full A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
title_fullStr A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
title_full_unstemmed A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
title_short A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
title_sort novel peanut allergy immunotherapy: plant-based enveloped ara h 2 bioparticles activate dendritic cells and polarize t cell responses to th1
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679945/
https://www.ncbi.nlm.nih.gov/pubmed/38020282
http://dx.doi.org/10.1016/j.waojou.2023.100839
work_keys_str_mv AT castenmillercharlotte anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT nagynoemianna anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT kroonpascalzion anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT augerlydia anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT desgagnesrejean anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT martelcaroline anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT mirandelucie anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT morelbertrand anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT robergejoannie anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT stordeurvirginie anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT tropperguy anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT vezinalouisphilipe anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT vanreeronald anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT gomordveronique anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT dejongestherchristina anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT castenmillercharlotte novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT nagynoemianna novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT kroonpascalzion novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT augerlydia novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT desgagnesrejean novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT martelcaroline novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT mirandelucie novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT morelbertrand novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT robergejoannie novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT stordeurvirginie novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT tropperguy novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT vezinalouisphilipe novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT vanreeronald novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT gomordveronique novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1
AT dejongestherchristina novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1